Abstract | PURPOSE OF REVIEW: In up to 10% of patients with bronchial asthma, aspirin and other nonsteroidal antiinflammatory drugs precipitate asthmatic attacks. This is a hallmark of a distinct clinical syndrome that develops according to a characteristic sequence of symptoms. Here we discuss its clinical picture and management as related to the abnormalities in arachidonic acid transformations. RECENT FINDINGS: SUMMARY:
|
Authors | Andrew Szczeklik, Marek Sanak, Ewa Nizankowska-Mogilnicka, Bogumila Kiełbasa |
Journal | Current opinion in pulmonary medicine
(Curr Opin Pulm Med)
Vol. 10
Issue 1
Pg. 51-6
(Jan 2004)
ISSN: 1070-5287 [Print] United States |
PMID | 14749606
(Publication Type: Journal Article, Review)
|
Chemical References |
- Cyclooxygenase 2 Inhibitors
- Cyclooxygenase Inhibitors
- Isoenzymes
- Leukotrienes
- Lipoxins
- Membrane Proteins
- Cyclooxygenase 2
- PTGS2 protein, human
- Prostaglandin-Endoperoxide Synthases
- Aspirin
|
Topics |
- Aspirin
(adverse effects)
- Asthma
(chemically induced, diagnosis, drug therapy, epidemiology, physiopathology)
- Cyclooxygenase 2
- Cyclooxygenase 2 Inhibitors
- Cyclooxygenase Inhibitors
(adverse effects)
- Desensitization, Immunologic
- Humans
- Isoenzymes
(antagonists & inhibitors)
- Leukotrienes
(metabolism)
- Lipoxins
(physiology)
- Mast Cells
(physiology)
- Membrane Proteins
- Prostaglandin-Endoperoxide Synthases
- Rhinitis
(epidemiology)
- Sinusitis
(epidemiology)
|